Antonio Clavenna

Off-label prescribing in pediatrics: between regulatory gaps and clinical evidence

Despite important regulatory progress, evidence supporting the use of medicines in children remains limited, and off-label prescribing continues to be common in pediatric practice. Regulatory initiatives such as the United States Pediatric Research Equity Act (PREA) and the Europ...